Osr

(NASDAQ) OSRH

Current Price$0.47

Market Cap$17.05M

Since IPO (2023)-95%

5 YearN/A

1 Year-54%

1 Month+30%

Osr last closing stock price
Metric	Price	Date
Last close	USD 0.49	2026-07-16

Osr stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+47.6%	USD 0.33	2026-07-09
1 month	+30.01%	USD 0.37	2026-06-16
3 month	-14.81%	USD 0.57	2026-04-17
Year to date	-13.92%	USD 0.56	2025-12-31
1 year	-53.75%	USD 1.05	2025-07-16
3 year	-95.29%	USD 10.30	2023-07-17
Since inception	-95.19%	USD 10.10	2023-03-17

Osr Financials at a Glance

Market Cap

$17.05M

Revenue (TTM)

$2.63M

Net Income (TTM)

-$13.80M

EPS (TTM)

-$0.36

P/E Ratio

-1.35

Dividend

$0.00

Beta (Volatility)

0.44 (Low)

Dividend

$0.00

Beta (Volatility)

0.44 (Low)

Price

$0.47

Volume

1,175,730

Open

$0.50

Price

$0.47

Volume

1,175,730

Open

$0.50

Previous Close

$0.47

Daily Range

$0.45 - $0.50

52-Week Range

$0.30 - $1.24

Estimated Earnings Date

Sep 2, 2026

Dividend

$0.00

Beta (Volatility)

0.44 (Low)

Price

$0.47

Volume

1,175,730

Open

$0.50

Previous Close

$0.47

Daily Range

$0.45 - $0.50

52-Week Range

$0.30 - $1.24

Estimated Earnings Date

Sep 2, 2026

OSRH News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Osr

OSR Holdings develops cancer immunotherapies and distributes medical devices for hospitals. Its products help doctors treat cancer and support surgeries. The company also works on non-invasive health monitoring for patients.

What’s in the Toolbox? (Products and Services)

Medical Device Distribution (RMC): Distributes neurovascular surgical devices in Korea; 100% of 2025 revenue.
Oral Cancer Immunotherapies (Vaximm): Develops oral medicines to help the immune system fight cancer; no sales yet.
Biologics for Bone and Joint Health (Darnatein): Creates new treatments for bone and cartilage repair; no sales yet.
Non-Invasive Biosensing (Woori IO): Develops technology for painless glucose and health monitoring; acquired in 2026.

Growth Spurts and Bold Moves

Transitioned from a blank check company to healthcare operator in February 2025.
Acquired Woori IO in January 2026, entering biosensing technology.
Signed global license deal with BCM Europe AG for cancer immunotherapy in 2025.
Shifted RMC to a fourth-party logistics (4PL) model in 2025, aiming to consolidate Korean device distribution.

Why OSR Holdings Is a Bit Different

The company uses a holding model, managing several healthcare businesses under one roof. It focuses on both medical devices and new therapies, spreading risk across different markets. Its intellectual property covers multiple countries, supporting long-term development.

Five Things You Need to Know

All 2025 revenue came from medical device distribution in Korea.
Net sales were $2.9 million in 2025, down 18% from 2024.
Operating loss was $4 million in Q3 2025, up from $454,000 in Q3 2024.
Cash and cash equivalents were $1.7 million as of December 31, 2025.
R&D spending nearly doubled in 2025, reaching $318,446.

Bottom Line

OSR Holdings has shifted from a blank check company to a diversified healthcare group. Its mix of device sales and early-stage therapies shows adaptability but faces ongoing financial and operational challenges.

AI Generated • Apr 16, 2026

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Peter Hwang

Website

www.osr-holdings.com

Headquarters

Bellevue, WA 98004, US

OSRH Financials

Key Financial Metrics (TTM)

Gross Margin

-70.05%

Operating Margin

-726.07%

Net Income Margin

-525.08%

Return on Equity

-15.90%

Return on Capital

-22.35%

Return on Assets

-8.02%

Earnings Yield

-74.07%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$17.05M

Shares Outstanding

35.12M

Volume

1.18M

Avg. Volume

6.41M

Financials (TTM)

Gross Profit

-$1.84M

Operating Income

-$19.09M

EBITDA

-$11.44M

Operating Cash Flow

-$5.27M

Capital Expenditure

-$176.39K

Free Cash Flow

-$5.44M

Cash & ST Invst.

$1.57M

Total Debt

$4.95M

Osr Performance Analysis

Osr annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	USD 0	N/A
2023	2023-12-31	USD 0	N/A
2024	2024-12-31	USD 3,530,303	N/A
2025	2025-12-31	USD 2,905,805	-17.7%

Osr sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	49.2%
Q3	2025-09-30	-44.7%
Q4	2025-12-31	-39.3%
Q1	2026-03-31	27.0%

Osr annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	USD -0.00	875.0%
2023	2023-12-31	USD 0.07	N/A
2024	2024-12-31	USD -4.79	N/A
2025	2025-12-31	USD -0.92	-80.7%

Osr sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	100.8%
Q3	2025-09-30	-3650.0%
Q4	2025-12-31	-184.5%
Q1	2026-03-31	61.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$484.06K

-36.4%

Gross Profit

-$2.27M

-1443.0%

Gross Margin

-4.68%

N/A

Market Cap

$17.05M

N/A

Market Cap/Employee

$775.16K

N/A

Employees

N/A

Net Income

-$2.93M

+74.3%

EBITDA

-$1.46M

+83.9%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$1.57M

-1.8%

Total Debt

$4.95M

+3.6%

Accounts Receivable

$526.26K

-34.2%

Inventory

$462.46K

-37.2%

Long Term Debt

$281.04K

+0.6%

Short Term Debt

$4.67M

+3.8%

Return on Assets

-8.02%

N/A

Return on Invested Capital

-12.37%

N/A

Free Cash Flow

-$1.00M

-1463.9%

Operating Cash Flow

-$1.00M

-1463.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BRLIBrilliant Acquisition Corporation

BRLIBrilliant Acquisition Corporation$4.70-45.85%

RFACRF Acquisition Corp.

RFACRF Acquisition Corp.$2.70-68.60%

ATIFATIF Holdings Ltd.

ATIFATIF Holdings Ltd.$0.64-12.79%

SFESSafeguard Scientifics, Inc.

SFESSafeguard Scientifics, Inc.$0.40+0.00%

JVSAJV SPAC Acquisition Corp. Class A Ordinary Share

JVSAJV SPAC Acquisition Corp. Class A Ordinary Share$3.64-65.98%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

ONDSOndas

ONDSOndas$6.53-0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98-0.04%

NFLXNetflix

NFLXNetflix$68.95-0.07%

PATHUiPath

PATHUiPath$12.15+0.01%

JOBYJoby Aviation

JOBYJoby Aviation$7.23-0.01%

SOFISoFi Technologies

SOFISoFi Technologies$17.28-0.00%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$123.99-0.05%

Questions About OSRH

What is the current price of Osr?

Osr is trading at $0.47 per share.

What is the 52-week range for Osr?

Over the past 52 weeks, Osr has traded between $0.30 and $1.24.

How much debt does Osr have?

As of the most recent reporting period, Osr reported total debt of $4.95M.

How much cash does Osr have on hand?

Osr reported $1.57M in cash and cash equivalents in its most recent financial results.

What is Osr’s dividend yield?

Osr does not currently have a dividend yield.

Osr

Osr Financials at a Glance

OSRH News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Osr

What’s in the Toolbox? (Products and Services)

Growth Spurts and Bold Moves

Why OSR Holdings Is a Bit Different

Five Things You Need to Know

Bottom Line

OSRH Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Osr Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About OSRH

What is the current price of Osr?

What is the 52-week range for Osr?

How much debt does Osr have?

How much cash does Osr have on hand?

What is Osr’s dividend yield?

Premium Investing Services